Mergers & Acquisitions - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

1 to 25 of 665 results

Johnson & Johnson to acquire Alios BioPharma

Johnson & Johnson to acquire Alios BioPharma

30-09-2014

US health care giant Johnson & Johnson has signed a definitive agreement to acquire Alios BioPharma,…

AL-8176Alios BioPharmaAnti-viralsJohnson & JohnsonMergers & AcquisitionsPharmaceuticalUSA

Lumara Health to be acquired in two separate deals for up to $1.107 billion

Lumara Health to be acquired in two separate deals for up to $1.107 billion

29-09-2014

Closely-held USA-based Lumara Health (previously K-V Pharmaceutical) today announced that it has entered…

AMAG PharmaceuticalsClindesseEvamistGynazoleLumara HealthMakenaMergers & AcquisitionsPerrigoPharmaceuticalUSAWomen's Health

Perrigo sells some preclinical assets to Imago

Perrigo sells some preclinical assets to Imago

29-09-2014

US heath care firm Perrigo says it has transferred a portfolio of preclinical research assets, which…

Imago PharmaceuticalsMergers & AcquisitionsNeurologicalPerrigoPharmaceuticalUSA

Horizon Discovery acquires Sage Labs for $48 million

Horizon Discovery acquires Sage Labs for $48 million

29-09-2014

UK-based Horizon Discovery Group has agreed to acquire Sage Labs of the USA for up to $16 million in…

GeneticsHorizon DiscoveryMergers & AcquisitionsPharmaceuticalSage LabsUKUSA

Actavis approached by Pfizer in latest takeover deal, according to sources

Actavis approached by Pfizer in latest takeover deal, according to sources

24-09-2014

US pharma giant Pfizer has held talks regarding an acquisition of Ireland-headquartered generics major…

ActavisMergers & AcquisitionsPfizerPharmaceuticalUSA

Avalon Ventures and GlaxoSmithKline launch two new companies

23-09-2014

Avalon Ventures today announced the launch of two new companies formed through its collaboration with…

Avalon VenturesFinancialGlaxoSmithKlineHematologyMergers & AcquisitionsPharmaceuticalRare diseasesSilarus TherapeuticsThyritope Biosciences

NovaDel sells ZolpiMist NDA, license and IP to Amherst Pharma

23-09-2014

NovaDel Pharma has sold its insomnia drug ZolpiMist (zolpidem oral spray) New Drug Application to fellow…

Amherst PharmaceuticalsMergers & AcquisitionsNeurologicalNovaDel PharmaPharmaceuticalUSAZolpiMist

US Treasury to crack down on tax inversion M&A deals

US Treasury to crack down on tax inversion M&A deals

23-09-2014

The USA’s Department of the Treasury announced on Monday that it is taking action to reduce the tax…

FinancialMergers & AcquisitionsPharmaceuticalPoliticsUSA

Auxilium Pharma rejects Endo acquisition in favor of QLT deal

Auxilium Pharma rejects Endo acquisition in favor of QLT deal

22-09-2014

Auxilium Pharmaceuticals’ board of directors, after review of the unsolicited $2.2 billion takeover…

AuxiliumCanadaEndo InternationalMen's HealthMergers & AcquisitionsPharmaceuticalQLTUSA

Merck KGaA in $11 billion deal for Sigma-Aldrich

Merck KGaA in $11 billion deal for Sigma-Aldrich

22-09-2014

Germany’s life sciences group Merck KGaA has entered into a definitive agreement to acquire USA-based…

GermanyMerck KGaAMergers & AcquisitionsMilliporePharmaceuticalSigma-Aldrich

Endo offers to buy Auxilium Pharmaceuticals for $2.2 billion

Endo offers to buy Auxilium Pharmaceuticals for $2.2 billion

17-09-2014

Ireland-domiciled pain drugmaker Endo International has delivered an unsolicited proposal to acquire…

Auxilium PharmaceuticalsEndo InternationalMergers & AcquisitionsNeurologicalPharmaceuticalQLTWomen's HealthXiaflex

Nicox acquires ophthalmic company Doliage and Carragelose eyedrops from Marinomed

Nicox acquires ophthalmic company Doliage and Carragelose eyedrops from Marinomed

16-09-2014

French ophthalmic company Nicox has advanced its strategy of building an international business by acquiring…

CarrageloseEuropeMarinomed BiotechnologiesMergers & AcquisitionsNicOxOphthalmicsPharmaceutical

UK M&A regulator consults on more stringent regulations

UK M&A regulator consults on more stringent regulations

16-09-2014

Partly in response to the recent (failed, thus far) attempt by US pharma giant Pfizer to acquire Anglo-Swedish…

LegalMergers & AcquisitionsPfizerPharmaceuticalUK

Ario Pharma acquires PharmEste’s TRPA1 research assets

11-09-2014

Cambridge, UK-based biopharma company Ario Pharma says it has acquired the TRPA1 antagonist research…

Ario PharmaInflammatory diseasesMergers & AcquisitionsPharmaceuticalPharmEsteRespiratory and Pulmonary

Luye Pharma to acquire majority stake in Beijing Jialin for $599 million

Luye Pharma to acquire majority stake in Beijing Jialin for $599 million

03-09-2014

Hong Kong-based Luye Pharma has entered into an agreement to purchase a 57.98% stake of Beijing Jialin…

Beijing Jialin PharmaceuticalCardio-vascularChinaLuye PharmaMergers & AcquisitionsPharmaceutical

FTC puts conditions on acquisition of Insight Pharma by Prestige Brands

29-08-2014

US firm Prestige Brands Holdings, the maker of Dramamine (dimenhydrinate), has agreed to divest assets…

Insight PharmaceuticalsMergers & AcquisitionsPharmaceuticalPrestige BrandsRegulationUSA

Tau Therapeutics and Xdynia merge to form Cavion

29-08-2014

Privately-held US drugmakers Tau Therapeutics and Xdynia announced today that they have merged; the surviving…

CavionMergers & AcquisitionsNeurologicalOncologyPharmaceuticalTau TherapeuticsXdynia

Novo Nordisk buys production plant in New Hampshire

Novo Nordisk buys production plant in New Hampshire

27-08-2014

Danish diabetes care giant Novo Nordisk (NOV: N) said today that it has acquired a manufacturing facility…

Mergers & AcquisitionsNovo NordiskOlympus BiotechPharmaceuticalProductionUSA

Allergan moves to block Valeant and Pershing Square from voting shares acquired in violation of insider trading laws

27-08-2014

Hostile takeover target Allergan has asked the US District Court for the Central District of California…

AllerganLegalMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals International

China Biologic to up equity stake in Guizhou Taibang

China Biologic to up equity stake in Guizhou Taibang

26-08-2014

Plasma-based biopharma firm China Biologic Products says that its wholly-owned subsidiary Guiyang Dalin…

ChinaChina Biologic ProductsGuizhou Eakan PharmaceuticalGuizhou Taibang BiologicalMergers & AcquisitionsPharmaceutical

Roche makes another acquisition, paying $8.3 billion for InterMune

Roche makes another acquisition, paying $8.3 billion for InterMune

25-08-2014

Announcing its fourth acquisition this year, Swiss pharma major Roche said on Sunday that it has entered…

EsbrietInterMuneMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryRoche

Pershing Square and other shareholders call for special meeting regarding Allergan hostile bid

Pershing Square and other shareholders call for special meeting regarding Allergan hostile bid

23-08-2014

Pershing Square Capital Management, the largest shareholder of Allergan, which is the subject of a $53…

AllerganManagementMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals International

Pfizer could try to acquire Actavis as back-up to a further bid for AstraZeneca

Pfizer could try to acquire Actavis as back-up to a further bid for AstraZeneca

22-08-2014

While speculation continues as to whether Pfizer will resume its attempts to buy AstraZeneca, Pfizer…

ActavisAstraZenecaBusiness FinanceIrelandMergers & AcquisitionsPfizerPharmaceuticalSwedenUKUnited StatesUSA

Mood lifts for Medtech in first half of 2014, while Pharma sector faces new struggles

Mood lifts for Medtech in first half of 2014, while Pharma sector faces new struggles

20-08-2014

An M&A frenzy that accounted for nearly $90 billion of equity set the pace for the first half of 2014…

FinancialGlobalJonathan GardnerMergers & AcquisitionsPharmaceutical

1 to 25 of 665 results

Back to top